• E-mail
• Print
• Comment
• Font Size
• Digg
• del.icio.us
• Discuss article

Teleflex Medical Expands Respiratory Offering With Nasal-Aire II Critical Care

Posted on: Tuesday, 13 September 2005, 12:00 CDT

The Teleflex Medical Products, a division of Teleflex Incorporated (NYSE:TFX), announced today it has entered an exclusive U.S. distribution agreement for the Nasal-Aire(R) II Critical Care patient interface developed by InnoMed Technologies, Inc.

"We are very pleased with our new relationship with Teleflex Medical," stated Sanjay Chandran, CEO of InnoMed Technologies, "It is the ideal business partner to bring the patented Nasal-Aire(R) technology into the critical care marketplace."

The Nasal-Aire(R) II Critical Care patient interface is a single patient use, disposable device intended for use in the hospital and other critical care settings for the administration of non-invasive ventilation (NIV). It features a patented nosepiece unique to the marketplace that seals on the inside of the nose rather than being compressed against it. This design makes the bulky headgear required to achieve a seal with traditional NIV patient interfaces obsolete, eliminating pressure on the face and bridge of the nose. This patient-friendly device also allows the user to converse, eat, drink and wear glasses while receiving therapy, actions that cannot easily be done with other NIV mask options.

"We are very excited about the prospect of selling the Nasal-Aire(R) II Critical Care interface product as it complements our existing lines and our future initiatives in NIV," said Richard Kindberg, Senior Vice President Teleflex Medical and General Manager of the Medical Products Division. Kindberg explained further, "We are also confident that the improved level of patient comfort this product offers will lead to increased therapy compliance and better patient outcomes - all at an affordable price."

About Teleflex Medical

Teleflex Medical, a division of Teleflex Incorporated, is a leading global supplier of disposable medical products, surgical instruments and medical devices. The division supports health providers along the continuum of care in three main areas:

-- Devices for urology, anesthesiology, gastroenterology and respiratory care

-- Surgical instruments and related services

-- Original Equipment Manufacturers

Teleflex Medical markets health care supplies under the Hudson RCI and Rusch brand names and surgical instruments and medical devices under the Beere, CVevolutions, Deknatel, KMedic, Pilling and Week brands. In 2004, Teleflex Medical had revenues of $745 million.

About InnoMed Technologies

InnoMed Technologies, Inc. is a global corporation involved in R&D, manufacturing and marketing of medical devices to treat sleep apnea and other respiratory disorders. With headquarters in Coconut Creek, FL, the company is responsible for the design and introduction to the market of the patented Nasal-Aire(R) technology and many other innovative medical products. Additional information on InnoMed Technologies can be obtained at http://www.InnoMedInc.com.

About Teleflex Incorporated

Teleflex Incorporated (NYSE:TFX) is a diversified company with annual revenues of $2.4 billion. Teleflex designs, manufactures and distributes quality engineered products and services for the aerospace, automotive, marine, industrial and medical markets worldwide. Headquartered in Limerick, PA, with operations in 26 countries, Teleflex employs more than 20,000 people worldwide who focus on providing innovative solutions for customers. Additional information about Teleflex, including a recent archived conference call with analysts and investors, can be obtained from the Company's website on the Internet at http://www.Teleflex.com.

Source: Business Wire

More News in this Category